Manni Mohyuddin: Bispecifics and CAR-T’s in myeloma trials

Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared on X:

“What we know so far about secondary primary cancers and myeloid malignancies with bispecifics and CAR-T’s in myeloma trials. Lots of unknowns.

Key to note that control arms of both randomized CAR-T trials had 0 cases of myeloid malignancies.”